# Pliant Therapeutics, Inc.: Form 8-K, filed Nov 10, 2020

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2020-11-10
- Accepted by EDGAR: Nov 10, 2020, 16:18 ET
- Period: 2020-11-10
- Accession: 0001564590-20-052983
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000156459020052983/plrx-8k_20201110.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000156459020052983/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000156459020052983/plrx-8k_20201110.htm

Filed Nov 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-052983. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
